Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Aug-24 4:38 PM View:  | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-Aug-24 | Payment of Exercise | 493 | $0.86 | $423.98 | (< 1%) 194.42K to 193.92K | |
| 27-Aug-24 4:37 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-24 | Payment of Exercise | 1,371 | $0.86 | $1,179.06 | (< 1%) 828.74K to 827.37K | |
| 27-Aug-24 4:36 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Aug-24 | Payment of Exercise | 7,492 | $0.86 | $6,443.12 | (< 1%) 2.53M to 2.53M | |
| 27-Aug-24 4:37 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-24 | Payment of Exercise | 1,508 | $0.86 | $1,296.88 | (< 1%) 846.11K to 844.6K | |
| 27-Aug-24 4:38 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Aug-24 | Payment of Exercise | 1,371 | $0.86 | $1,179.06 | (< 1%) 831.37K to 830.0K | |
| 27-Aug-24 4:37 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 24-Aug-24 | Payment of Exercise | 1,787 | $0.86 | $1,536.82 | (< 1%) 847.89K to 846.11K | |
| 27-Aug-24 4:38 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 24-Aug-24 | Payment of Exercise | 1,430 | $0.86 | $1,229.80 | (< 1%) 832.8K to 831.37K | |
| 27-Aug-24 4:38 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 24-Aug-24 | Payment of Exercise | 703 | $0.86 | $604.58 | (< 1%) 195.12K to 194.42K | |
| 27-Aug-24 4:37 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 24-Aug-24 | Payment of Exercise | 1,787 | $0.86 | $1,536.82 | (< 1%) 830.53K to 828.74K | |
| 27-Aug-24 4:36 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 24-Aug-24 | Payment of Exercise | 5,261 | $0.86 | $4,524.46 | (< 1%) 2.54M to 2.53M | |
| 15-Aug-24 4:34 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 13-Aug-24 | Payment of Exercise | 892 | $0.98 | $869.79 | (< 1%) 833.69K to 832.8K | |
| 13-Jun-24 4:42 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 11-Jun-24 | Payment of Exercise | 892 | $0.61 | $542.07 | (< 1%) 831.42K to 830.53K | |
| 06-Jun-24 4:25 PM View: | Meyers James R Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 50% 49.6K to 74.6K | |
| 06-Jun-24 4:25 PM View: | Parker H Stewart Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 40% 62.6K to 87.6K | |
| 06-Jun-24 4:24 PM View: | Markels John Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 54% 46.38K to 71.38K | |
| 06-Jun-24 4:23 PM View: | Hillan Kenneth Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 50% 49.6K to 74.6K | |
| 06-Jun-24 4:24 PM View: | Horn Margaret A Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 77% 32.65K to 57.65K | |
| 06-Jun-24 4:23 PM View: | Beers Courtney Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 77% 32.65K to 57.65K | |
| 06-Jun-24 4:26 PM View: | Smith Karen L. Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 48% 52.1K to 77.1K | |
| 06-Jun-24 4:23 PM View: | Carey Robert Director | Sangamo Biosciences Inc. (SGMO) | 04-Jun-24 | Grant | 25,000 | -- | -- | 50% 49.6K to 74.6K | |
| 29-May-24 4:57 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-24 | Payment of Exercise | 1,371 | $0.60 | $822.60 | (< 1%) 832.79K to 831.42K | |
| 29-May-24 5:15 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-May-24 | Payment of Exercise | 1,336 | $0.60 | $801.60 | (< 1%) 835.03K to 833.69K | |
| 29-May-24 5:00 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-May-24 | Payment of Exercise | 493 | $0.60 | $295.80 | (< 1%) 195.61K to 195.12K | |
| 29-May-24 4:54 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-May-24 | Payment of Exercise | 7,492 | $0.60 | $4,495.20 | (< 1%) 2.55M to 2.54M | |
| 29-May-24 5:18 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-24 | Payment of Exercise | 1,508 | $0.60 | $904.80 | (< 1%) 844.4K to 842.89K | |
| 29-May-24 5:15 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 24-May-24 | Payment of Exercise | 1,400 | $0.60 | $840.00 | (< 1%) 836.43K to 835.03K | |
| 29-May-24 5:00 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 24-May-24 | Payment of Exercise | 702 | $0.60 | $421.20 | (< 1%) 196.31K to 195.61K | |
| 29-May-24 4:54 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 24-May-24 | Payment of Exercise | 5,261 | $0.60 | $3,156.60 | (< 1%) 2.55M to 2.55M | |
| 29-May-24 5:18 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 24-May-24 | Payment of Exercise | 1,787 | $0.60 | $1,072.20 | (< 1%) 846.19K to 844.4K | |
| 29-May-24 4:57 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 24-May-24 | Payment of Exercise | 1,787 | $0.60 | $1,072.20 | (< 1%) 834.58K to 832.79K | |
| 27-Feb-24 5:13 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 5,010 | $1.13 | $5,661.30 | (< 1%) 851.2K to 846.19K | |
| 27-Feb-24 5:12 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 3,453 | $1.13 | $3,901.89 | (< 1%) 838.03K to 834.58K | |
| 27-Feb-24 5:13 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 3,453 | $1.13 | $3,901.89 | (< 1%) 839.88K to 836.43K | |
| 27-Feb-24 5:14 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 2,459 | $1.13 | $2,778.67 | (1%) 198.77K to 196.31K | |
| 27-Feb-24 5:11 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 24,157 | $1.13 | $27,297.40 | (< 1%) 2.58M to 2.55M | |
| 27-Feb-24 5:12 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 5,474 | $1.13 | $6,185.62 | (< 1%) 843.5K to 838.03K | |
| 27-Feb-24 5:13 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 4,379 | $1.13 | $4,948.27 | (< 1%) 844.26K to 839.88K | |
| 27-Feb-24 5:14 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 2,209 | $1.13 | $2,496.17 | (1%) 200.98K to 198.77K | |
| 27-Feb-24 5:11 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 16,115 | $1.13 | $18,209.90 | (< 1%) 2.59M to 2.58M | |
| 27-Feb-24 5:13 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 5,474 | $1.13 | $6,185.62 | (< 1%) 856.67K to 851.2K | |
| 24-Jan-24 4:40 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 494% 144.17K to 856.67K | |
| 24-Jan-24 4:41 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 544% 131.0K to 843.5K | |
| 24-Jan-24 4:42 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 541% 131.76K to 844.26K | |
| 24-Jan-24 4:42 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 150,000 | -- | -- | 294% 50.98K to 200.98K | |
| 24-Jan-24 4:39 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 2,000,000 | -- | -- | 338% 592.48K to 2.59M | |
| 28-Nov-23 4:20 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,329 | $0.38 | $507.81 | (1%) 128.09K to 126.76K | |
| 28-Nov-23 4:15 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 490 | $0.38 | $187.23 | (< 1%) 51.47K to 50.98K | |
| 28-Nov-23 4:18 PM View: | Fontenot Jason D. SVP, Chief Scientific Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,030 | $0.38 | $393.56 | (< 1%) 137.3K to 136.27K | |
| 28-Nov-23 4:19 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 10,411 | $0.38 | $3,978.04 | (2%) 602.89K to 592.48K | |
| 28-Nov-23 4:16 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,462 | $0.38 | $558.63 | (1%) 140.63K to 139.17K |
